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Abstract
Purpose: The purpose of this study was to investigate interobserver agreement during magnetic resonance cholangio­
pancreatography (MRCP) evaluation and the sensitivity and specificity of MRCP obtained with 3T scanners in cases 
of bile duct obstruction.
Material and methods: A total of 37 patients who had MRCP and endoscopic retrograde cholangiography (ERCP) were 
included. Choledochal pathology was divided into two groups regarding the presence of stones as “there is stone or 
not”. MRCPs were performed with a 3­Tesla system using respiratory triggered HASTE technique in axial and coronal 
planes and with T2 SPACE sequence in the coronal plane. Sensitivity, specificity, negative predictive value (NPV), 
and positive predictive value (PPV) were calculated separately for each observer. The average of both observers was 
calculated for comparison with other studies.
Results: Thirty­seven patients were in the study population. Agreement between the observers was analysed, and 
Cohen’s κ value was evaluated as 0.84. For two observers, the sensitivity of MRCP was 93%, whereas the specificity 
was 75% for the first observer and 62% for the second.
Conclusions: In this study we found a high level of interobserver agreement in evaluating MRCP. MRCP has a high 
sensitivity in detecting choledocholithiasis.
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Introduction
Biliary obstruction may be due to choledocholithiasis, 
tumours, trauma, or post­surgical strictures. An imaging 
method is used in conjunction with biochemical param­
eters for diagnosis. Endoscopic retrograde cholangio­
graphy (ERCP) is currently the gold standard diagnostic 
tool for the imaging of bile ducts [1]. However, the need 
for general anaesthesia for ERCP creates a disadvantage 
because it is an invasive and expensive procedure. Mag­
netic resonance cholangiopancreatography (MRCP) and 
endoscopic ultrasonography (EUS) are alternatives to 
ERCP as a method for noninvasive diagnostic imaging of 
bile ducts. There are several reports indicating that the 
sensitivity and specificity of MRCP in choledocholithia­
sis are 27­90% and 40­100%, respectively [1­6]. The lack 
of a concomitant therapeutic approach is a disadvantage 
of this method; for this reason, MRCP is usually followed 
by an invasive method. Because some reports show that 
MRCP does not change the management of suspected 
choledocholithiasis, the benefit for this group of patients 
is being questioned [2,3].
In literature, the majority of studies conducted on 
the sensitivity and specificity of MRCP were performed 
with 1.5T systems due to the widespread use of devices. 
Initially, SAR problems, coils mismatches, susceptibility 
artefacts, and penetration failure limited the use of 3T 
scanners [7]. However, recently the use of 3T scanners 
has increased by overcoming of these problems and with 
the development of new sequence structures.
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The purpose of this study is to investigate interobserv­
er agreement during MRCP evaluation and the sensitivi­
ty and specificity of MRCP obtained with 3T scanners in 
cases of bile duct obstruction.
Material and methods
Ethical approval was obtained from our university. Hospi­
tal records of 48 patients whose MRCPs were performed 
in the Radiology Clinic and ERCPs were performed in 
the Gastroenterology Clinic consecutively with suspect­
ed choledocholithiasis were evaluated between May 2017 
and October 2017. Seven patients considered with tumour 
by MRCP and ERCP and diagnosed histopathologically 
were excluded. Four of the patients with failed ERCP for 
different reasons were also excluded. In total, 37 patients 
who had MRCP and ERCP were included. The patients 
were evaluated by two experienced radiologists. The ra­
diologists were blinded to each other and the diagnosis 
of the patients. 
Choledochal pathology was divided into two groups 
depending on the presence of stones as “there is stone or 
not”. Extrahepatic bile duct diameters were measured. 
Gall bladder was examined for the presence of stones. 
Bio chemical parameters such as alanine aminotransferase 
(ALT), aspartate aminotransferase (AST), gamma­glutam­
yl transferase (GGT), alkaline phosphatase (ALP), and to­
tal bilirubin values were recorded. 
MRCP was performed with a 3­Tesla (Siemens Skyra, 
Erlangen, Germany) system using respiratory­triggered 
HASTE technique in axial and coronal planes and with 
a T2 SPACE sequence in the coronal plane. Images of the 
T2 SPACE sequence were then reconstructed to maximum 
intensity projection (MIP) images in the coronal plane 
with 10 degrees (totally 36 images). Sequence parameters 
are given in Table 1. 
ERCP techniques were performed with a side­viewed 
Pentax ED 3490 duodenoscope (Tokyo, Japan). Bile ducts 
were cannulated with a guidewire by sphincterotomy. 
Images were obtained with nonionic contrast materials. 
In cases of the presence of a stone, it was retrieved with 
a balloon catheter. 
Mann­Whitney U test was used to compare demo­
graphic and laboratory data. Cohen’s κ value was calcu­
lated for interobserver agreement. Sensitivity, specificity, 
negative predictive value (NPV), and positive predictive 
value (PPV) were calculated separately for each observer. 
The average of both observers was calculated for compar­
ison with other studies. All statistical analyses were done 
using SPSS software (IBM SPSS Statistics 20).
Results
Seven patients who had MRCP­ERCP comparison were 
diagnosed with tumours and were excluded from the 
study. Four of the patients who had ERCP failure for oth­
er reasons were also excluded. The ERCP failure rate was 
8.33%. The reasons for failure were as follows: fibrotic pa­
pilla, papillary oedema, the papilla could not be found in 
one patient with gastroenterostomy, and papilla was placed 
at the rim of duodenal diverticula in another patient. 
Thirty­seven patients were included in the study pop­
ulation. The average age of the study population was 63.51 
(14­91) years. Fifteen of the patients were male and 22 were 
female. The average age of the male patients was 68.67 
(20­91) years and of the female patients was 60 (14­91) 
Table 1. Parameters of sequences used in magnetic resonance cholangio-
pancreatography
TR 
(msn)
TE 
(msn)
Slice thickness 
(mm)
FOV 
(cm)
Axial HASTE 1600 95 5 37 × 29
Coronal HASTE 1400 108 5 37 × 34
T2 SPACE 4489 702 1 37 × 37
Table 2. Demographic, biochemical, and ultrasonographic data of the cases
No choledocholithiasis (n = 7)
(Median, min, max)
Choledocholithiasis (n = 30)
(Median, min, max)
p value
Age (year) 56 (14-72) 69.50 (27-91) 0.029
Total bilirubin (mg/dl) 1.70 (0.28-7.05) 2.75 (0.49-11.45) 0.406
AST (U/l) 49 (28-257) 65 (10-552) 0.815
ALT (U/l) 62 (20-307) 95 (10-587) 0.815
GGT (U/l) 225 (19-546) 250 (20-1397) 0.410
ALP (U/l) 102 (55-308) 155 (23-667) 0.178
Cholelithiasis (n) 5 18
Cholecystectomies (n) 2 12
CBD diameter (mm) 5 (3-8) 11.65 (6-23) < 0.001
CBD – common bile duct, min – minimum, max – maximum
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years. Demographic features and laboratory data are sum­
marised in Table 2. 
The average time between MRCP and ERCP was 5.46 
(1­15) days. The median bile duct size of the seven pa­
tients whose MRCP and ERCP results were evaluated as 
normal was 5 mm (3­8 mm). The median bile duct size 
was 11.65 mm (6­23) in 30 patients with choledocholi­
thiasis.
The agreement between the observers was analysed, 
and Cohen’s κ value was evaluated as 0.84. For two ob­
servers, the sensitivity of MRCP was 93% whereas the 
specificity was 75% for the first observer and 62% for the 
second. Sensitivity, specificity, accuracy, PPV, and NPV 
values are shown in Table 3. 
Discussion
In this study, MRCP was compared with ERCP, and the 
sensitivity of MRCP in patients with choledocholithiasis 
was found to be 93% and specificity 69%. The sensitivity of 
MRCP is reported as being between 27% and 100% in the 
literature [2,5,6]. In our study, the sensitivity of MRCP that 
we found was similar to that of the high­level sensitivity 
groups in studies in the literature. Some studies found the 
specificity of MRCP to be between 40% and 100%. In this 
perspective, in our study, the sensitivity result seems to be 
in the medium sensitivity group [1,4]. In a comparison of 
the specificity value with other series, we found a lower 
value because the first observer reported suspected stone 
in the bile ducts of two patients and the second observer 
in three patients. Both observers interpreted false positive 
stones in the same cases. The time between MRCP and 
ERCP of these patients was 3­5 days. There was a dark 
focus in the axial HASTE series in the central distal por­
tion of the bile duct in two patients who had false positive 
Table 3. Sensitivity, specificity, positive predictive value (PPV), negative 
predictive value (NPV), and accuracy values both observers
Sensitivity
(%)
Specificity
(%)
PPV
(%)
NPV 
(%)
Accuracy
(%)
Observer 1 93 75 93 75 89
Observer 2 93 62 90 71 86
Figure 1. A) There was a hypointensity in axial HASTE series in central por-
tion of distal bile duct (choledoc: arrowhead) (gall bladder: open arrow). 
B, C) This hypointensity was not seen in coronal HASTE and T2 SPACE MIP 
images
A
C
B
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Table 4. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) reported in the literature for MRCP in patients with 
suspected choledocholithiasis
Author Year Scanner (Tesla) n Sensitivity (%) Specificity (%) PPV (%) NPV (%)
Present study 2017 3T 37 93 69 91.5 73
Makmun [1] 2017 1.5 31 81 40 74 50
Badger [2]** 2016 1.5 or 3 47 90 86 97 60
Aydelotte [3] 2015 1.5 36 90 88 97 64
Polistina [4] 2015 1.5 111 77.4 100 100 85
Richard* [5] 2013 NR 70 27 83 36 77
Demartine [6] 2000 1.5 40 100 95.6 92.6 100
*In this study, MRCP was compared with intraoperative cholangiography 
**In this study, MRCP was compared with intraoperative cholangiography or ERCP 
NR – not reported
choledocholithiasis as reported by both of the observ­
ers (Figure 1A). This dark focus was not seen in coronal 
HASTE and T2 SPACE images (Figure 1B­C). It is thought 
that it could be due to the flow because the location of this 
false image is in the central distal portion of bile duct and 
only seen in the axial plane. Millimetric stones and sludge 
were reported in the ERCP of false negative cases.
We also examined the agreement between observers. 
Cohen’s κ value was calculated as 0.84. This value shows 
that the agreement between the observers is quite good. 
Although there are studies concerning interobserver agree­
ment of MRCP sequences, there is no adequate evidence 
and discussion about interobserver agreement of MRCP in 
patients with suspected choledocholithiasis [8,9]. 
In the first evaluation of patients with suspected chole­
docholithiasis, blood tests (ALT, AST, GGT, ALP, and total 
bilirubin) and transabdominal ultrasonography (TAUS) 
should be performed [10]. Levels of cholestatic biochem­
ical markers (GGT, ALP, and bilirubin) usually increase 
gradually, consistent with the duration and severity of bil­
iary obstruction. However, these biochemical tests are not 
specific to choledocholithiasis and can increase in some 
other conditions like pancreatitis in the first line. No statis­
tical significance was found in levels of biochemical tests in 
patients with choledocholithiasis and in patients without 
choledocholithiasis in this study. In the group of patients 
without choledocholithiasis, one patient had hepatitis and 
sludge in the gall bladder, one patient had cholecystitis, 
and two other patients had pancreatitis. The other three 
patients were investigated because of complaints that de­
veloped after cholecystectomy and the establishment of 
large bile duct in ultrasonography. The last patient had 
increased levels in biochemical tests but normalised in the 
following tests. 
Normally the bile duct diameter is smaller than 6 mm 
[11]. A mild dilation is reported to be normal due to aging 
[12]. Biliary obstruction should be suggested when the 
bile duct diameter is over 8 mm in patients with normal 
gallbladder [13]. In the group of patients without choledo­
cholithiasis in our study, the maximum bile duct diameter 
was evaluated as 8 mm; this was in the patient with chole­
cystectomy. TAUS has a low sensitivity in detecting CBD 
stones. However, it is more reliable in detecting dilation in 
the bile duct due to choledocholithiasis [14,15]. 
ERCP is the reference diagnostic method in biliary ob­
struction [16]. In patients with obstructive jaundice, the 
ERCP failure rate is about 6­7% [17]. The rate we found 
in our study was 8.33%. This rate is slightly higher than re­
ported. ERCP is recommended in patients with cholelithi­
asis and with high risk of choledocholithiasis before the op­
eration. In patients with ERCP failure, EUS and MRCP are 
recommended [10]. In our opinion, it seems more rational 
to perform MRCP before ERCP in order to give a broad 
overview and detect lesions other than choledocholithiasis.
There are some limitations in our study. Nonparamet­
ric tests were used for comparison of the groups when the 
number was limited in the group of patients without chole­
docholithiasis. There was a delay between MRCP and ERCP 
because it was a retrospective study. The average delay was 
5.46 days and in some of the patients it prolonged to 15 days. 
During this time interval, although it is a low probability, the 
persistence of stones in the bile duct might have changed, 
and this situation might have caused false negative results. 
Conclusions
As a result, in this study we found a high level of in­
terobserver agreement in evaluating MRCP. MRCP has 
a high sensitivity in detecting choledocholithiasis. How­
ever, the specificity found in this study was comparatively 
low, and this may be due to artefacts caused by high mag­
netic field. Further long­term studies are needed. 
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